Artikel ; Online: Evaluación y perspectiva de 20 años de cribado neonatal en Galicia. Resultados del programa.
Revista espanola de salud publica
2020 Band 94
Abstract: Galician newborn screening program for early detection of endocrine and metabolic diseases began in 1978 and was a pioneer in expanded newborn screening in Spain with the incorporation of mass spectrometry in July 2000. As a primary objective, 28 ... ...
| Titelübersetzung | Evaluation and perspective of 20 years of neonatal screening in Galicia. Program results. |
|---|---|
| Abstract | Galician newborn screening program for early detection of endocrine and metabolic diseases began in 1978 and was a pioneer in expanded newborn screening in Spain with the incorporation of mass spectrometry in July 2000. As a primary objective, 28 diseases are screened, including those recommended SNS except sickle cell anemia which is in the inclusion phase. In its 20-year history, 404,616 newborns (nb) have been analyzed, identifying 547 cases affected by the diseases included, with a global incidence of 1: 739 newborns and 1: 1.237 of the screened inborn errors of metabolism (IEM) (1:1.580 nb if excluding benign hyperphenylalaninemia-HPA), with an average participation of 99.35%, progressively higher during the analyzed period. Among the pathologies screened, congenital hypothyroidism (1:2.211 nb), cystinuria (1:4.129 nb) and HPA (1:5.699 nb), followed by phenylketonuria and cystic fibrosis (1:10,936 nb) stand out for their incidence. Sixty-six cases of false positives were identified (seventeen of them in relation to maternal pathology) and five false negatives, being the overall PPV and NPV of the program respectively of 89.2% and 99.99%, with a sensitivity of 99.09% and a specificity of 99.98%. The mortality rate of diagnosed CME patients is 1.52%, with eleven cases presenting symptoms prior to the screening result (2%). The intelligence quotient of IEM patients at risk of neurological involvement is normal in more than 95% of cases. |
| Mesh-Begriff(e) | Congenital Hypothyroidism/diagnosis ; Congenital Hypothyroidism/epidemiology ; Cystic Fibrosis/diagnosis ; Cystic Fibrosis/epidemiology ; False Positive Reactions ; Female ; Humans ; Incidence ; Infant, Newborn ; Male ; Metabolism, Inborn Errors/diagnosis ; Metabolism, Inborn Errors/epidemiology ; Neonatal Screening/methods ; Neonatal Screening/standards ; Neonatal Screening/trends ; Program Evaluation ; Sensitivity and Specificity ; Spain/epidemiology |
| Sprache | Spanisch |
| Erscheinungsdatum | 2020-12-16 |
| Erscheinungsland | Spain |
| Dokumenttyp | Evaluation Study ; Journal Article |
| ZDB-ID | 1288657-9 |
| ISSN | 2173-9110 ; 0034-8899 ; 1135-5727 |
| ISSN (online) | 2173-9110 |
| ISSN | 0034-8899 ; 1135-5727 |
| Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
| Zs.A 483: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.